-
-
Use of B-Type Natriuretic Peptide in the Evaluation and Management of
Acute Dyspnea; Association Between C-Reactive Protein and Age-Related Macular Degeneration; VZV Reactivation in Astronauts
-
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized.
-
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women.
-
-
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer.
-
These data provide further support that inflammation in general and periodontal disease more specifically are stroke risk factors.
-
High-dose atorvastatin protects patients with acute coronary syndrome from death and major cardiovascular events better than usual dose pravastatin.
-
-
SynCardia Systems (Tucson, Arizona), a developer of cardiac replacement and assist devices, in mid-October received final FDA approval for its CardioWest Temporary Total Artificial Heart (TAH-t) formerly the CardioWest Total Artificial Heart as a bridge to heart transplantation. Specifically, the approval is for use in cardiac transplant-eligible candidates at risk of imminent death from non-reversible biventricular failure.
